TY - JOUR
T1 - Meningiomas
AU - Grimm, Sean
AU - Raizer, Jeffrey J
PY - 2008/12/1
Y1 - 2008/12/1
N2 - Meningiomas, the most common intracranial tumors, are dura-based tumors that occur in middle-aged or older adults and have a predilection for women and African Americans. They are almost always benign, but atypical and malignant forms exist. The optimal treatment for symptomatic tumors is complete surgical resection when feasible. Tumors in poor locations can have a higher rate of morbidity and often can be only partially removed. Radiation therapy should be used to treat lesions that are partially removed and lesions of higher grade, despite complete removal. Small lesions may be amenable to radiosurgery, which may obviate surgery in high-risk patients. For lesions that recur or grow despite surgery and radiation, the only option is systemic chemotherapy. No agent is optimal, but hydroxyurea is used most often. Newer approaches such as the use of inhibitors of somatostatin receptors or signal transduction pathways are under investigation.
AB - Meningiomas, the most common intracranial tumors, are dura-based tumors that occur in middle-aged or older adults and have a predilection for women and African Americans. They are almost always benign, but atypical and malignant forms exist. The optimal treatment for symptomatic tumors is complete surgical resection when feasible. Tumors in poor locations can have a higher rate of morbidity and often can be only partially removed. Radiation therapy should be used to treat lesions that are partially removed and lesions of higher grade, despite complete removal. Small lesions may be amenable to radiosurgery, which may obviate surgery in high-risk patients. For lesions that recur or grow despite surgery and radiation, the only option is systemic chemotherapy. No agent is optimal, but hydroxyurea is used most often. Newer approaches such as the use of inhibitors of somatostatin receptors or signal transduction pathways are under investigation.
UR - http://www.scopus.com/inward/record.url?scp=58649115577&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=58649115577&partnerID=8YFLogxK
U2 - 10.1007/s11940-008-0034-9
DO - 10.1007/s11940-008-0034-9
M3 - Review article
C2 - 18579018
AN - SCOPUS:58649115577
SN - 1092-8480
VL - 10
SP - 315
EP - 320
JO - Current Treatment Options in Neurology
JF - Current Treatment Options in Neurology
IS - 4
ER -